IBDEI1LX ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,62,0)
 ;;=BREASTS and GYN NEOPLASMS^3^9
 ;;^UTILITY(U,$J,358.4,63,0)
 ;;=COAGULATION DISORDERS^4^9
 ;;^UTILITY(U,$J,358.4,64,0)
 ;;=COUNSELING AND SCREENING^5^9
 ;;^UTILITY(U,$J,358.4,65,0)
 ;;=GENITOURINARY NEOPLASMS^6^9
 ;;^UTILITY(U,$J,358.4,66,0)
 ;;=GI CANCER^7^9
 ;;^UTILITY(U,$J,358.4,67,0)
 ;;=HEAD NECK AND LUNGS NEOPLASMS^8^9
 ;;^UTILITY(U,$J,358.4,68,0)
 ;;=HEMOGLOBINOPATHIES^9^9
 ;;^UTILITY(U,$J,358.4,69,0)
 ;;=LYMPHOID NEOPLASMS^10^9
 ;;^UTILITY(U,$J,358.4,70,0)
 ;;=METASTATIC SITES^13^9
 ;;^UTILITY(U,$J,358.4,71,0)
 ;;=MALIGNANT NEOPLASMS OF OTHER SITES^11^9
 ;;^UTILITY(U,$J,358.4,72,0)
 ;;=MYELOID NEOPLASMS AND DISORDERS^14^9
 ;;^UTILITY(U,$J,358.4,73,0)
 ;;=NEOPLASM OF UNCERTAIN BEHAVIOR^15^9
 ;;^UTILITY(U,$J,358.4,74,0)
 ;;=NEOPLASM OF UNSPECIFIED NATURE^16^9
 ;;^UTILITY(U,$J,358.4,75,0)
 ;;=PERSONAL HISTORY^19^9
 ;;^UTILITY(U,$J,358.4,76,0)
 ;;=MALNUTRITION^12^9
 ;;^UTILITY(U,$J,358.4,77,0)
 ;;=OTHER^18^9
 ;;^UTILITY(U,$J,358.4,78,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^20^9
 ;;^UTILITY(U,$J,358.4,79,0)
 ;;=ACOUSTIC NERVE INJURIES^1^10
 ;;^UTILITY(U,$J,358.4,80,0)
 ;;=AUDITORY DISORDERS^2^10
 ;;^UTILITY(U,$J,358.4,81,0)
 ;;=BALANCE DISORDERS^3^10
 ;;^UTILITY(U,$J,358.4,82,0)
 ;;=BAROTRAUMA^4^10
 ;;^UTILITY(U,$J,358.4,83,0)
 ;;=EAR DISEASE^5^10
 ;;^UTILITY(U,$J,358.4,84,0)
 ;;=FOREIGN BODIES^7^10
 ;;^UTILITY(U,$J,358.4,85,0)
 ;;=HEARING LOSS^8^10
 ;;^UTILITY(U,$J,358.4,86,0)
 ;;=NOISE INJURIES^9^10
 ;;^UTILITY(U,$J,358.4,87,0)
 ;;=NYSTAGMUS^10^10
 ;;^UTILITY(U,$J,358.4,88,0)
 ;;=OTOTOXICITY^11^10
 ;;^UTILITY(U,$J,358.4,89,0)
 ;;=PURPOSE OF ENCOUNTER/HEALTH STATUS^12^10
 ;;^UTILITY(U,$J,358.4,90,0)
 ;;=EXTERNAL EAR DISEASES^6^10
 ;;^UTILITY(U,$J,358.4,91,0)
 ;;=NEW PATIENT^2^11
 ;;^UTILITY(U,$J,358.4,92,0)
 ;;=ESTABLISHED PATIENT^1^11
 ;;^UTILITY(U,$J,358.4,93,0)
 ;;=CONSULTATIONS^3^11
 ;;^UTILITY(U,$J,358.4,94,0)
 ;;=AUDIOLOGIC FUNCTION TESTS^1^12
 ;;^UTILITY(U,$J,358.4,95,0)
 ;;=SCREENING^12^12
 ;;^UTILITY(U,$J,358.4,96,0)
 ;;=COCHLEAR IMPLANT^2^12
 ;;^UTILITY(U,$J,358.4,97,0)
 ;;=OTHER TREATMENT^9^12
 ;;^UTILITY(U,$J,358.4,98,0)
 ;;=DISPENSING^4^12
 ;;^UTILITY(U,$J,358.4,99,0)
 ;;=REMOVAL FOREIGN BODY/CERUMEN^11^12
 ;;^UTILITY(U,$J,358.4,100,0)
 ;;=VESTIBULAR FUNCT W/ RECORDING^14^12
 ;;^UTILITY(U,$J,358.4,101,0)
 ;;=VESTIBULAR FUNCT W/O RECORDING^15^12
 ;;^UTILITY(U,$J,358.4,102,0)
 ;;=EVALUATIVE & THERAPEUTIC SVCS^5^12
 ;;^UTILITY(U,$J,358.4,103,0)
 ;;=TEAM CONFERENCE^13^12
 ;;^UTILITY(U,$J,358.4,104,0)
 ;;=PROLONGED CLINICAL STAFF SERVICES^10^12
 ;;^UTILITY(U,$J,358.4,105,0)
 ;;=OTHER SERVICES^8^12
 ;;^UTILITY(U,$J,358.4,106,0)
 ;;=DEVICES & EQUIPMENT^3^12
 ;;^UTILITY(U,$J,358.4,107,0)
 ;;=EXCISION^6^12
 ;;^UTILITY(U,$J,358.4,108,0)
 ;;=INCISION^7^12
 ;;^UTILITY(U,$J,358.4,109,0)
 ;;=NEW PATIENT^2^13
 ;;^UTILITY(U,$J,358.4,110,0)
 ;;=ESTABLISHED PATIENT^1^13
 ;;^UTILITY(U,$J,358.4,111,0)
 ;;=CONSULTATIONS^3^13
 ;;^UTILITY(U,$J,358.4,112,0)
 ;;=ARRHYTHMIA^3^14
 ;;^UTILITY(U,$J,358.4,113,0)
 ;;=CHEST PAIN^4^14
 ;;^UTILITY(U,$J,358.4,114,0)
 ;;=CHF/MYOPATHY/TRANSPLANT^5^14
 ;;^UTILITY(U,$J,358.4,115,0)
 ;;=CORONARY ATHEROSCLEROSIS^6^14
 ;;^UTILITY(U,$J,358.4,116,0)
 ;;=GENERAL SYMPTOMS^9^14
 ;;^UTILITY(U,$J,358.4,117,0)
 ;;=HISTORY^12^14
 ;;^UTILITY(U,$J,358.4,118,0)
 ;;=HYPERTENSION/HYPOTENSION^13^14
 ;;^UTILITY(U,$J,358.4,119,0)
 ;;=INFECTION/INFLM DISEASE^14^14
 ;;^UTILITY(U,$J,358.4,120,0)
 ;;=LIPID DISORDER^15^14
 
--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1LX   3788     printed  Sep 23, 2025@19:47:17                                                                                                                                                                                                    Page 2
IBDEI1LX  ; ; 01-FEB-2022
 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 +2        if 'DIFQR(358.4)
               QUIT 
           FOR I=1:2
               SET X=$TEXT(Q+I)
               if X=""
                   QUIT 
               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
               SET X=$EXTRACT(X,4,999)
               if $ASCII(Y)=126
                   SET I=I+1
                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
               if $ASCII(Y)=61
                   SET Y=$EXTRACT(Y,2,999)
               XECUTE NO
              IF '$TEST
                   SET @X=Y
Q          QUIT 
 +1       ;;^UTILITY(U,$J,358.4,62,0)
 +2       ;;=BREASTS and GYN NEOPLASMS^3^9
 +3       ;;^UTILITY(U,$J,358.4,63,0)
 +4       ;;=COAGULATION DISORDERS^4^9
 +5       ;;^UTILITY(U,$J,358.4,64,0)
 +6       ;;=COUNSELING AND SCREENING^5^9
 +7       ;;^UTILITY(U,$J,358.4,65,0)
 +8       ;;=GENITOURINARY NEOPLASMS^6^9
 +9       ;;^UTILITY(U,$J,358.4,66,0)
 +10      ;;=GI CANCER^7^9
 +11      ;;^UTILITY(U,$J,358.4,67,0)
 +12      ;;=HEAD NECK AND LUNGS NEOPLASMS^8^9
 +13      ;;^UTILITY(U,$J,358.4,68,0)
 +14      ;;=HEMOGLOBINOPATHIES^9^9
 +15      ;;^UTILITY(U,$J,358.4,69,0)
 +16      ;;=LYMPHOID NEOPLASMS^10^9
 +17      ;;^UTILITY(U,$J,358.4,70,0)
 +18      ;;=METASTATIC SITES^13^9
 +19      ;;^UTILITY(U,$J,358.4,71,0)
 +20      ;;=MALIGNANT NEOPLASMS OF OTHER SITES^11^9
 +21      ;;^UTILITY(U,$J,358.4,72,0)
 +22      ;;=MYELOID NEOPLASMS AND DISORDERS^14^9
 +23      ;;^UTILITY(U,$J,358.4,73,0)
 +24      ;;=NEOPLASM OF UNCERTAIN BEHAVIOR^15^9
 +25      ;;^UTILITY(U,$J,358.4,74,0)
 +26      ;;=NEOPLASM OF UNSPECIFIED NATURE^16^9
 +27      ;;^UTILITY(U,$J,358.4,75,0)
 +28      ;;=PERSONAL HISTORY^19^9
 +29      ;;^UTILITY(U,$J,358.4,76,0)
 +30      ;;=MALNUTRITION^12^9
 +31      ;;^UTILITY(U,$J,358.4,77,0)
 +32      ;;=OTHER^18^9
 +33      ;;^UTILITY(U,$J,358.4,78,0)
 +34      ;;=SUICIDE IDEATIONS/ATTEMPTS^20^9
 +35      ;;^UTILITY(U,$J,358.4,79,0)
 +36      ;;=ACOUSTIC NERVE INJURIES^1^10
 +37      ;;^UTILITY(U,$J,358.4,80,0)
 +38      ;;=AUDITORY DISORDERS^2^10
 +39      ;;^UTILITY(U,$J,358.4,81,0)
 +40      ;;=BALANCE DISORDERS^3^10
 +41      ;;^UTILITY(U,$J,358.4,82,0)
 +42      ;;=BAROTRAUMA^4^10
 +43      ;;^UTILITY(U,$J,358.4,83,0)
 +44      ;;=EAR DISEASE^5^10
 +45      ;;^UTILITY(U,$J,358.4,84,0)
 +46      ;;=FOREIGN BODIES^7^10
 +47      ;;^UTILITY(U,$J,358.4,85,0)
 +48      ;;=HEARING LOSS^8^10
 +49      ;;^UTILITY(U,$J,358.4,86,0)
 +50      ;;=NOISE INJURIES^9^10
 +51      ;;^UTILITY(U,$J,358.4,87,0)
 +52      ;;=NYSTAGMUS^10^10
 +53      ;;^UTILITY(U,$J,358.4,88,0)
 +54      ;;=OTOTOXICITY^11^10
 +55      ;;^UTILITY(U,$J,358.4,89,0)
 +56      ;;=PURPOSE OF ENCOUNTER/HEALTH STATUS^12^10
 +57      ;;^UTILITY(U,$J,358.4,90,0)
 +58      ;;=EXTERNAL EAR DISEASES^6^10
 +59      ;;^UTILITY(U,$J,358.4,91,0)
 +60      ;;=NEW PATIENT^2^11
 +61      ;;^UTILITY(U,$J,358.4,92,0)
 +62      ;;=ESTABLISHED PATIENT^1^11
 +63      ;;^UTILITY(U,$J,358.4,93,0)
 +64      ;;=CONSULTATIONS^3^11
 +65      ;;^UTILITY(U,$J,358.4,94,0)
 +66      ;;=AUDIOLOGIC FUNCTION TESTS^1^12
 +67      ;;^UTILITY(U,$J,358.4,95,0)
 +68      ;;=SCREENING^12^12
 +69      ;;^UTILITY(U,$J,358.4,96,0)
 +70      ;;=COCHLEAR IMPLANT^2^12
 +71      ;;^UTILITY(U,$J,358.4,97,0)
 +72      ;;=OTHER TREATMENT^9^12
 +73      ;;^UTILITY(U,$J,358.4,98,0)
 +74      ;;=DISPENSING^4^12
 +75      ;;^UTILITY(U,$J,358.4,99,0)
 +76      ;;=REMOVAL FOREIGN BODY/CERUMEN^11^12
 +77      ;;^UTILITY(U,$J,358.4,100,0)
 +78      ;;=VESTIBULAR FUNCT W/ RECORDING^14^12
 +79      ;;^UTILITY(U,$J,358.4,101,0)
 +80      ;;=VESTIBULAR FUNCT W/O RECORDING^15^12
 +81      ;;^UTILITY(U,$J,358.4,102,0)
 +82      ;;=EVALUATIVE & THERAPEUTIC SVCS^5^12
 +83      ;;^UTILITY(U,$J,358.4,103,0)
 +84      ;;=TEAM CONFERENCE^13^12
 +85      ;;^UTILITY(U,$J,358.4,104,0)
 +86      ;;=PROLONGED CLINICAL STAFF SERVICES^10^12
 +87      ;;^UTILITY(U,$J,358.4,105,0)
 +88      ;;=OTHER SERVICES^8^12
 +89      ;;^UTILITY(U,$J,358.4,106,0)
 +90      ;;=DEVICES & EQUIPMENT^3^12
 +91      ;;^UTILITY(U,$J,358.4,107,0)
 +92      ;;=EXCISION^6^12
 +93      ;;^UTILITY(U,$J,358.4,108,0)
 +94      ;;=INCISION^7^12
 +95      ;;^UTILITY(U,$J,358.4,109,0)
 +96      ;;=NEW PATIENT^2^13
 +97      ;;^UTILITY(U,$J,358.4,110,0)
 +98      ;;=ESTABLISHED PATIENT^1^13
 +99      ;;^UTILITY(U,$J,358.4,111,0)
 +100     ;;=CONSULTATIONS^3^13
 +101     ;;^UTILITY(U,$J,358.4,112,0)
 +102     ;;=ARRHYTHMIA^3^14
 +103     ;;^UTILITY(U,$J,358.4,113,0)
 +104     ;;=CHEST PAIN^4^14
 +105     ;;^UTILITY(U,$J,358.4,114,0)
 +106     ;;=CHF/MYOPATHY/TRANSPLANT^5^14
 +107     ;;^UTILITY(U,$J,358.4,115,0)
 +108     ;;=CORONARY ATHEROSCLEROSIS^6^14
 +109     ;;^UTILITY(U,$J,358.4,116,0)
 +110     ;;=GENERAL SYMPTOMS^9^14
 +111     ;;^UTILITY(U,$J,358.4,117,0)
 +112     ;;=HISTORY^12^14
 +113     ;;^UTILITY(U,$J,358.4,118,0)
 +114     ;;=HYPERTENSION/HYPOTENSION^13^14
 +115     ;;^UTILITY(U,$J,358.4,119,0)
 +116     ;;=INFECTION/INFLM DISEASE^14^14
 +117     ;;^UTILITY(U,$J,358.4,120,0)
 +118     ;;=LIPID DISORDER^15^14